Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-01

AUTHORS

Konstantinos I. Votanopoulos, Andrea Mazzocchi, Hemamylammal Sivakumar, Steven Forsythe, Julio Aleman, Edward A. Levine, Aleksander Skardal

ABSTRACT

INTRODUCTION: We have hypothesized that biofabrication of appendiceal tumor organoids allows for a more personalized clinical approach and facilitates research in a rare disease. METHODS: Appendiceal cancer specimens obtained during cytoreduction with hyperthermic intraperitoneal chemotherapy procedures (CRS/HIPEC) were dissociated and incorporated into an extracellular matrix-based hydrogel system as three-dimensional (3D), patient-specific tumor organoids. Cells were not sorted, preserving tumor heterogeneity, including stroma and immune cell components. Following establishment of organoid sets, chemotherapy drugs were screened in parallel. Live/dead staining and quantitative metabolism assays recorded which chemotherapies were most effective in killing cancer cells for a specific patient. Maintenance of cancer phenotypes were confirmed by using immunohistochemistry. RESULTS: Biospecimens from 12 patients were applied for organoid development between November 2016 and May 2018. Successful establishment rate of viable organoid sets was 75% (9/12). Average time from organoid development to chemotherapy testing was 7 days. These tumors included three high-grade appendiceal (HGA) and nine low-grade appendiceal (LGA) primaries obtained from sites of peritoneal metastasis. All tumor organoids were tested with chemotherapeutic agents exhibited responses that were either similar to the patient response or within the variability of the expected clinical response. More specifically, HGA tumor organoids derived from different patients demonstrated variable chemotherapy tumor-killing responses, whereas LGA organoids tested with the same regimens showed no response to chemotherapy. One LGA set of organoids was immune-enhanced with cells from a patient-matched lymph node to demonstrate feasibility of a symbiotic 3D reconstruction of a patient matched tumor and immune system component. CONCLUSIONS: Development of 3D appendiceal tumor organoids is feasible even in low cellularity LGA tumors, allowing for individual patient tumors to remain viable for research and personalized drug screening. More... »

PAGES

1-9

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-018-7008-2

DOI

http://dx.doi.org/10.1245/s10434-018-7008-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1109801247

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30414038


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Department of Surgery \u2013 Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA", 
            "Comprehensive Cancer Center at Wake Forest Baptist Medical, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Votanopoulos", 
        "givenName": "Konstantinos I.", 
        "id": "sg:person.01155643513.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155643513.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest University", 
          "id": "https://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA", 
            "Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mazzocchi", 
        "givenName": "Andrea", 
        "id": "sg:person.07672654660.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07672654660.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest University", 
          "id": "https://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sivakumar", 
        "givenName": "Hemamylammal", 
        "id": "sg:person.015675637356.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015675637356.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest University", 
          "id": "https://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA", 
            "Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Forsythe", 
        "givenName": "Steven", 
        "id": "sg:person.01270761777.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270761777.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest University", 
          "id": "https://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aleman", 
        "givenName": "Julio", 
        "id": "sg:person.01072531465.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072531465.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Department of Surgery \u2013 Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA", 
            "Comprehensive Cancer Center at Wake Forest Baptist Medical, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levine", 
        "givenName": "Edward A.", 
        "id": "sg:person.01362075400.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362075400.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest University", 
          "id": "https://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Comprehensive Cancer Center at Wake Forest Baptist Medical, Winston-Salem, NC, USA", 
            "Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA", 
            "Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA", 
            "Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skardal", 
        "givenName": "Aleksander", 
        "id": "sg:person.01033434737.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033434737.72"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/2159-8290.cd-14-0001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000404010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-014-4147-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000934407", 
          "https://doi.org/10.1245/s10434-014-4147-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biomaterials.2012.03.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001413490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.actbio.2015.07.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001763644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jamcollsurg.2011.12.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010225928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-13-0087", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017991650"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbm.b.33736", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018279418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1039/9781782622055-00191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021110935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/1758-5090/7/3/031001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027066739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biomaterials.2010.04.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036020632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bit.25950", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053492530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/ten.tea.2009.0798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059315534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08879-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091232024", 
          "https://doi.org/10.1038/s41598-017-08879-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08879-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091232024", 
          "https://doi.org/10.1038/s41598-017-08879-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08879-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091232024", 
          "https://doi.org/10.1038/s41598-017-08879-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/ten.tea.2017.0397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091847991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-60511-1_4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092361205", 
          "https://doi.org/10.1007/978-3-319-60511-1_4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-60511-1_4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092361205", 
          "https://doi.org/10.1007/978-3-319-60511-1_4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-018-21200-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100901821", 
          "https://doi.org/10.1038/s41598-018-21200-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.aao2774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101186518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.aao2774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101186518"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01", 
    "datePublishedReg": "2019-01-01", 
    "description": "INTRODUCTION: We have hypothesized that biofabrication of appendiceal tumor organoids allows for a more personalized clinical approach and facilitates research in a rare disease.\nMETHODS: Appendiceal cancer specimens obtained during cytoreduction with hyperthermic intraperitoneal chemotherapy procedures (CRS/HIPEC) were dissociated and incorporated into an extracellular matrix-based hydrogel system as three-dimensional (3D), patient-specific tumor organoids. Cells were not sorted, preserving tumor heterogeneity, including stroma and immune cell components. Following establishment of organoid sets, chemotherapy drugs were screened in parallel. Live/dead staining and quantitative metabolism assays recorded which chemotherapies were most effective in killing cancer cells for a specific patient. Maintenance of cancer phenotypes were confirmed by using immunohistochemistry.\nRESULTS: Biospecimens from 12 patients were applied for organoid development between November 2016 and May 2018. Successful establishment rate of viable organoid sets was 75% (9/12). Average time from organoid development to chemotherapy testing was 7\u00a0days. These tumors included three high-grade appendiceal (HGA) and nine low-grade appendiceal (LGA) primaries obtained from sites of peritoneal metastasis. All tumor organoids were tested with chemotherapeutic agents exhibited responses that were either similar to the patient response or within the variability of the expected clinical response. More specifically, HGA tumor organoids derived from different patients demonstrated variable chemotherapy tumor-killing responses, whereas LGA organoids tested with the same regimens showed no response to chemotherapy. One LGA set of organoids was immune-enhanced with cells from a patient-matched lymph node to demonstrate feasibility of a symbiotic 3D reconstruction of a patient matched tumor and immune system component.\nCONCLUSIONS: Development of 3D appendiceal tumor organoids is feasible even in low cellularity LGA tumors, allowing for individual patient tumors to remain viable for research and personalized drug screening.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-018-7008-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }
    ], 
    "name": "Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study", 
    "pagination": "1-9", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d76ddcb5cd3be8defc0058a21f38707256804b7d995a69424a07ac64020babe7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30414038"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-018-7008-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1109801247"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-018-7008-2", 
      "https://app.dimensions.ai/details/publication/pub.1109801247"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8660_00000610.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1245%2Fs10434-018-7008-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-7008-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-7008-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-7008-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-7008-2'


 

This table displays all metadata directly associated to this object as RDF triples.

167 TRIPLES      21 PREDICATES      44 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-018-7008-2 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N5188bf214a1a4881a17d7cb67360e2e7
4 schema:citation sg:pub.10.1007/978-3-319-60511-1_4
5 sg:pub.10.1038/s41598-017-08879-x
6 sg:pub.10.1038/s41598-018-21200-8
7 sg:pub.10.1245/s10434-014-4147-y
8 https://doi.org/10.1002/bit.25950
9 https://doi.org/10.1002/jbm.b.33736
10 https://doi.org/10.1016/j.actbio.2015.07.030
11 https://doi.org/10.1016/j.biomaterials.2010.04.045
12 https://doi.org/10.1016/j.biomaterials.2012.03.034
13 https://doi.org/10.1016/j.jamcollsurg.2011.12.028
14 https://doi.org/10.1039/9781782622055-00191
15 https://doi.org/10.1088/1758-5090/7/3/031001
16 https://doi.org/10.1089/ten.tea.2009.0798
17 https://doi.org/10.1089/ten.tea.2017.0397
18 https://doi.org/10.1126/science.aao2774
19 https://doi.org/10.1158/0008-5472.can-13-0087
20 https://doi.org/10.1158/2159-8290.cd-14-0001
21 schema:datePublished 2019-01
22 schema:datePublishedReg 2019-01-01
23 schema:description INTRODUCTION: We have hypothesized that biofabrication of appendiceal tumor organoids allows for a more personalized clinical approach and facilitates research in a rare disease. METHODS: Appendiceal cancer specimens obtained during cytoreduction with hyperthermic intraperitoneal chemotherapy procedures (CRS/HIPEC) were dissociated and incorporated into an extracellular matrix-based hydrogel system as three-dimensional (3D), patient-specific tumor organoids. Cells were not sorted, preserving tumor heterogeneity, including stroma and immune cell components. Following establishment of organoid sets, chemotherapy drugs were screened in parallel. Live/dead staining and quantitative metabolism assays recorded which chemotherapies were most effective in killing cancer cells for a specific patient. Maintenance of cancer phenotypes were confirmed by using immunohistochemistry. RESULTS: Biospecimens from 12 patients were applied for organoid development between November 2016 and May 2018. Successful establishment rate of viable organoid sets was 75% (9/12). Average time from organoid development to chemotherapy testing was 7 days. These tumors included three high-grade appendiceal (HGA) and nine low-grade appendiceal (LGA) primaries obtained from sites of peritoneal metastasis. All tumor organoids were tested with chemotherapeutic agents exhibited responses that were either similar to the patient response or within the variability of the expected clinical response. More specifically, HGA tumor organoids derived from different patients demonstrated variable chemotherapy tumor-killing responses, whereas LGA organoids tested with the same regimens showed no response to chemotherapy. One LGA set of organoids was immune-enhanced with cells from a patient-matched lymph node to demonstrate feasibility of a symbiotic 3D reconstruction of a patient matched tumor and immune system component. CONCLUSIONS: Development of 3D appendiceal tumor organoids is feasible even in low cellularity LGA tumors, allowing for individual patient tumors to remain viable for research and personalized drug screening.
24 schema:genre research_article
25 schema:inLanguage en
26 schema:isAccessibleForFree false
27 schema:isPartOf sg:journal.1105545
28 schema:name Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study
29 schema:pagination 1-9
30 schema:productId N2fe5d7061dc4443cbb99574693b3cd01
31 N400a66daac4e4e339256d4f6cf53cab6
32 N4e099c2ad48f43d3a86d5ba3d2c22eb0
33 N5378a0f3e5974d4f99b25fd6937696c5
34 N9688c9d0ad01484580bfed75090fe8d6
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109801247
36 https://doi.org/10.1245/s10434-018-7008-2
37 schema:sdDatePublished 2019-04-10T14:24
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N1626c21d9f49468ea4fa868f36bb408e
40 schema:url https://link.springer.com/10.1245%2Fs10434-018-7008-2
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N1626c21d9f49468ea4fa868f36bb408e schema:name Springer Nature - SN SciGraph project
45 rdf:type schema:Organization
46 N16f0ee0f491441fc8d176cb860a87c44 rdf:first sg:person.01362075400.37
47 rdf:rest N447c294cf64f438fbae557e33db6825d
48 N2fe5d7061dc4443cbb99574693b3cd01 schema:name readcube_id
49 schema:value d76ddcb5cd3be8defc0058a21f38707256804b7d995a69424a07ac64020babe7
50 rdf:type schema:PropertyValue
51 N400a66daac4e4e339256d4f6cf53cab6 schema:name nlm_unique_id
52 schema:value 9420840
53 rdf:type schema:PropertyValue
54 N447c294cf64f438fbae557e33db6825d rdf:first sg:person.01033434737.72
55 rdf:rest rdf:nil
56 N4b24e012439d4595a3557603e46e17b3 rdf:first sg:person.015675637356.06
57 rdf:rest Nd73af01a2e6448fc9fb531ff61fcf007
58 N4e099c2ad48f43d3a86d5ba3d2c22eb0 schema:name pubmed_id
59 schema:value 30414038
60 rdf:type schema:PropertyValue
61 N5188bf214a1a4881a17d7cb67360e2e7 rdf:first sg:person.01155643513.53
62 rdf:rest N70280165a7ae41b0a510c5bc33d72508
63 N5378a0f3e5974d4f99b25fd6937696c5 schema:name doi
64 schema:value 10.1245/s10434-018-7008-2
65 rdf:type schema:PropertyValue
66 N70280165a7ae41b0a510c5bc33d72508 rdf:first sg:person.07672654660.06
67 rdf:rest N4b24e012439d4595a3557603e46e17b3
68 N9688c9d0ad01484580bfed75090fe8d6 schema:name dimensions_id
69 schema:value pub.1109801247
70 rdf:type schema:PropertyValue
71 Nafe98983762640df88dbcbc9fb0e72f8 rdf:first sg:person.01072531465.05
72 rdf:rest N16f0ee0f491441fc8d176cb860a87c44
73 Nd73af01a2e6448fc9fb531ff61fcf007 rdf:first sg:person.01270761777.91
74 rdf:rest Nafe98983762640df88dbcbc9fb0e72f8
75 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
76 schema:name Medical and Health Sciences
77 rdf:type schema:DefinedTerm
78 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
79 schema:name Oncology and Carcinogenesis
80 rdf:type schema:DefinedTerm
81 sg:journal.1105545 schema:issn 1068-9265
82 1534-4681
83 schema:name Annals of Surgical Oncology
84 rdf:type schema:Periodical
85 sg:person.01033434737.72 schema:affiliation https://www.grid.ac/institutes/grid.241167.7
86 schema:familyName Skardal
87 schema:givenName Aleksander
88 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033434737.72
89 rdf:type schema:Person
90 sg:person.01072531465.05 schema:affiliation https://www.grid.ac/institutes/grid.241167.7
91 schema:familyName Aleman
92 schema:givenName Julio
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072531465.05
94 rdf:type schema:Person
95 sg:person.01155643513.53 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
96 schema:familyName Votanopoulos
97 schema:givenName Konstantinos I.
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155643513.53
99 rdf:type schema:Person
100 sg:person.01270761777.91 schema:affiliation https://www.grid.ac/institutes/grid.241167.7
101 schema:familyName Forsythe
102 schema:givenName Steven
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270761777.91
104 rdf:type schema:Person
105 sg:person.01362075400.37 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
106 schema:familyName Levine
107 schema:givenName Edward A.
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362075400.37
109 rdf:type schema:Person
110 sg:person.015675637356.06 schema:affiliation https://www.grid.ac/institutes/grid.241167.7
111 schema:familyName Sivakumar
112 schema:givenName Hemamylammal
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015675637356.06
114 rdf:type schema:Person
115 sg:person.07672654660.06 schema:affiliation https://www.grid.ac/institutes/grid.241167.7
116 schema:familyName Mazzocchi
117 schema:givenName Andrea
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07672654660.06
119 rdf:type schema:Person
120 sg:pub.10.1007/978-3-319-60511-1_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092361205
121 https://doi.org/10.1007/978-3-319-60511-1_4
122 rdf:type schema:CreativeWork
123 sg:pub.10.1038/s41598-017-08879-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1091232024
124 https://doi.org/10.1038/s41598-017-08879-x
125 rdf:type schema:CreativeWork
126 sg:pub.10.1038/s41598-018-21200-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100901821
127 https://doi.org/10.1038/s41598-018-21200-8
128 rdf:type schema:CreativeWork
129 sg:pub.10.1245/s10434-014-4147-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1000934407
130 https://doi.org/10.1245/s10434-014-4147-y
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1002/bit.25950 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053492530
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1002/jbm.b.33736 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018279418
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1016/j.actbio.2015.07.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001763644
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1016/j.biomaterials.2010.04.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036020632
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/j.biomaterials.2012.03.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001413490
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/j.jamcollsurg.2011.12.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010225928
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1039/9781782622055-00191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021110935
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1088/1758-5090/7/3/031001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027066739
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1089/ten.tea.2009.0798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059315534
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1089/ten.tea.2017.0397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091847991
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1126/science.aao2774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101186518
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1158/0008-5472.can-13-0087 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017991650
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1158/2159-8290.cd-14-0001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000404010
157 rdf:type schema:CreativeWork
158 https://www.grid.ac/institutes/grid.241167.7 schema:alternateName Wake Forest University
159 schema:name Comprehensive Cancer Center at Wake Forest Baptist Medical, Winston-Salem, NC, USA
160 Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
161 Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA
162 Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA
163 rdf:type schema:Organization
164 https://www.grid.ac/institutes/grid.412860.9 schema:alternateName Wake Forest Baptist Medical Center
165 schema:name Comprehensive Cancer Center at Wake Forest Baptist Medical, Winston-Salem, NC, USA
166 Department of Surgery – Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA
167 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...